<?xml version="1.0" encoding="UTF-8" ?>
<rss version="2.0">
<channel>
<title>UM Ventures News</title>
<description>News from the AJ Clark School of Engineering</description>
<link>http://www.umventures.org/news/</link>
<lastBuildDate>Thu, 23 Jan 2014 13:28:25 EST</lastBuildDate>
<image>
<title>UM Ventures News</title>
<url>http://eng.umd.edu/images/clark_logo_4email.gif</url>
<link>http://www.umventures.org/news/</link>
</image>
<item>
<title><![CDATA[Rexahn Initiates Phase Ib Clinical Trial of RX-3117 for Treatment of Solid Tumors]]></title>
<description><![CDATA[RX-3117 has Shown Efficacy Against Gemcitabine-Resistant Human Cancer Cell Lines and a Broad-Spectrum of Anti-Cancer Activity]]></description>
<link>http://www.umventures.org/news/news_story.php?id=7915</link>
<pubDate>Thu, 09 Jan 2014 02:11:55 EST</pubDate>
<guid>http://www.umventures.org/news/news_story.php?id=7915</guid>
</item>
<item>
<title><![CDATA[PaxVax Announces Positive Interim Results for Phase 3 Cholera Challenge Study; Clinical Trial Program to Proceed as Planned]]></title>
<description><![CDATA[PaxVax Inc, which develops and commercializes innovative vaccines against infectious diseases in a socially responsible manner, announced interim data from a Phase 3 cholera challenge study of its single-dose oral cholera vaccine candidate, PXVX0200 (also known as CVD 103-HgR).]]></description>
<link>http://www.umventures.org/news/news_story.php?id=7914</link>
<pubDate>Thu, 09 Jan 2014 02:11:54 EST</pubDate>
<guid>http://www.umventures.org/news/news_story.php?id=7914</guid>
</item>
<item>
<title><![CDATA[Bioentrepreneurship Leader Joins UM Ventures Team]]></title>
<description><![CDATA[Martha Connolly Will Enhance UMD-UMB Innovation Ecosystem.]]></description>
<link>http://www.umventures.org/news/news_story.php?id=7891</link>
<pubDate>Mon, 06 Jan 2014 14:04:20 EST</pubDate>
<guid>http://www.umventures.org/news/news_story.php?id=7891</guid>
</item>
<item>
<title><![CDATA[Three Companies with UMB Roots Make Progress in Late 2013]]></title>
<description><![CDATA[<span>Three health-focused companies with UM Baltimore roots&amp;nbsp;have&amp;nbsp;announced important&amp;nbsp;commercial&amp;nbsp;progress.</span>]]></description>
<link>http://www.umventures.org/news/news_story.php?id=7850</link>
<pubDate>Mon, 16 Dec 2013 14:31:10 EST</pubDate>
<guid>http://www.umventures.org/news/news_story.php?id=7850</guid>
</item>
<item>
<title><![CDATA[Jim Hughes and UM Ventures Featured on BioBuzz]]></title>
<description><![CDATA[A year ago, James L. Hughes, M.B.A., vice president and chief enterprise and economic development officer at University of Maryland, Baltimore (UMB), was named director of University of Maryland Ventures (UM Ventures),]]></description>
<link>http://www.umventures.org/news/news_story.php?id=7824</link>
<pubDate>Mon, 18 Nov 2013 02:10:24 EST</pubDate>
<guid>http://www.umventures.org/news/news_story.php?id=7824</guid>
</item>
<item>
<title><![CDATA[New IBBR Director Envisions Premier Biotechnology Research Institute]]></title>
<description><![CDATA[The University of Maryland announced on November 13 the appointment of Thomas R. Fuerst, Ph.D., as the new director of the Institute for Bioscience and Biotechnology Research (IBBR).]]></description>
<link>http://www.umventures.org/news/news_story.php?id=7823</link>
<pubDate>Wed, 13 Nov 2013 02:10:23 EST</pubDate>
<guid>http://www.umventures.org/news/news_story.php?id=7823</guid>
</item>
<item>
<title><![CDATA[UMB Licensee Countervail Corporation Receives Additional $5.4 Million from BARDA for Continued Development of Medical Countermeasure to Nerve Agents]]></title>
<description><![CDATA[Countervail Corporation announced on November 8 that the Department of Health and Human Services (HHS), through the Biomedical Advanced Research and Development Authority (BARDA), has exercised a contract option for an additional $5.4 million for the further development of galantamine hydrobromide.]]></description>
<link>http://www.umventures.org/news/news_story.php?id=7822</link>
<pubDate>Tue, 12 Nov 2013 02:10:22 EST</pubDate>
<guid>http://www.umventures.org/news/news_story.php?id=7822</guid>
</item>
<item>
<title><![CDATA[Alba Therapeutics Names New CEO]]></title>
<description><![CDATA[Baltimore Sun - Nov. 4, 2013: Baltimore biotech firm Alba Therapeutics said Monday that it has promoted its president to CEO.]]></description>
<link>http://www.umventures.org/news/news_story.php?id=7821</link>
<pubDate>Mon, 04 Nov 2013 02:10:21 EST</pubDate>
<guid>http://www.umventures.org/news/news_story.php?id=7821</guid>
</item>
<item>
<title><![CDATA[Nobel Laureate Comes to Campus to Share His Love of Science]]></title>
<description><![CDATA[As part of the Nobel Prize Inspiration Initiative, Nobel Laureate Craig Mello, PhD, came to the University of Maryland School of Medicine on November 4. The Nobel Prize Inspiration Initiative is a global program designed to help Nobel Laureates share their inspirational stories and insights.]]></description>
<link>http://www.umventures.org/news/news_story.php?id=7820</link>
<pubDate>Mon, 04 Nov 2013 02:10:20 EST</pubDate>
<guid>http://www.umventures.org/news/news_story.php?id=7820</guid>
</item>
<item>
<title><![CDATA[Gliknik's David Block Among Featured Speakers at Maryland Entrepreneur Breakfast]]></title>
<description><![CDATA[On October 29, Gliknik Inc. CEO David Block shared his company's story of success to date &amp;ndash; including a recently announced licensing agreement with Pfizer &amp;ndash; at the Maryland Entrepreneur Breakfast in Baltimore, hosted by the Maryland Department of Business &amp;amp; Economic Development.]]></description>
<link>http://www.umventures.org/news/news_story.php?id=7819</link>
<pubDate>Tue, 29 Oct 2013 02:10:19 EDT</pubDate>
<guid>http://www.umventures.org/news/news_story.php?id=7819</guid>
</item>
</channel>
</rss>